V25I (p.Val25Ile) variant of CDKN2A (Tumor suppressor ARF)

V25I (p.Val25Ile) in CDKN2A (Tumor suppressor ARF) is a missense change. Clinical records from ClinVar and UniProt describe it as uncertain significance in the context of Familial melanoma. The available variant effect predictions contribute to a CATVariant prioritization score of 0.22 / 1. The record also includes population frequency data.

V25I (p.Val25Ile) variant details